Picture of Molecular Templates logo

MTEMQ — Molecular Templates News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Molecular Templates Announces FDA Acceptance Of IND Application For MT-6402

Jan 19 (Reuters) - Molecular Templates Inc  MTEM.O :
    * MOLECULAR TEMPLATES ANNOUNCES FDA ACCEPTANCE OF IND
APPLICATION
FOR MT-6402, A PD-L1-TARGETED ENGINEERED TOXIN BODY ENABLED WITH
PROPRIETARY ANTIGEN SEEDING TECHNOLOGY
    * MOLECULAR TEMPLATES - EXPECTS TO START DOSING ENROLLED
SUBJECTS
IN PHASE 1 STUDY IN RELAPSED/REFRACTORY PATIENTS WITH
PD-L1-POSITIVE SOLID TUMORS IN Q2

Source text for Eikon:  ID:nGNX3CJ6Fv 
Further company coverage:  MTEM.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Molecular Templates

See all news